Skip to main content
Premium Trial:

Request an Annual Quote

Mediation for Helicos Suit Against PacBio, Life Tech, and Illumina Rescheduled for Early 2012

Premium

Mediation conferences to potentially resolve Helicos BioSciences' patent lawsuit against Pacific Biosciences, Life Technologies, and Illumina have been rescheduled for early 2012, according to a court order filed this week.

Originally, the conferences had been scheduled for late August of this year but were canceled due to a hurricane on the East Coast (IS 7/26/2011 and IS 9/13/2011).

Helicos is now scheduled to meet with PacBio on Jan. 17 or 18, or on April 24, 2012, depending on the court's availability; with Illumina on Feb. 13; and with Life Tech on Feb. 14.

Helicos first filed the suit against PacBio in late 2010 in the US District Court for the District of Delaware, claiming that PacBio's sequencing technology infringes four of its patents, and later added Illumina and Life Tech as defendants to the suit.

PacBio, Illumina, and Life Tech later countersued Helicos, claiming that several of the patents are invalid and unenforceable.

Separately, the United States Patent and Trademark Office initiated the reexamination of several Helicos patents, including those under dispute, following requests from PacBio and Life Tech (IS 9/13/2011).

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.